JBF Capital Inc. purchased a new position in Sio Gene Therapies Inc. (NASDAQ:SIOX – Get Rating) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 429,600 shares of the company’s stock, valued at approximately $187,000. JBF Capital Inc. owned […]
Susquehanna International Group LLP acquired a new position in shares of Sio Gene Therapies Inc. (NASDAQ:SIOX – Get Rating) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 95,387 shares of the company’s stock, valued at approximately $41,000. Susquehanna International […]
Sio Gene Therapies Inc. (NASDAQ:SIOX – Get Rating)’s share price was up 2.2% during trading on Friday . The stock traded as high as $0.41 and last traded at $0.41. Approximately 57,376 shares traded hands during trading, a decline of 89% from the average daily volume of 505,344 shares. The stock had previously closed at […]
Sio Gene Therapies (NASDAQ:SIOX – Get Rating) and Organigram (NASDAQ:OGI – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, profitability and dividends. Earnings & Valuation This table compares Sio Gene Therapies […]